Company Profiles

driven by the PitchBook Platform

HyperMed Imaging

Description

Developer of medical imaging devices designed to assess oxyhemoglobin, deoxyhemoglobin and oxyhemoglobin saturation in superficial tissue for a number of key healthcare applications. The company's medical imaging devices use a proprietary spectrometer to measure light absorption in blood molecules to determine levels of oxyhemoglobin and deoxyhemoglobin and oxygen saturation in superficial tissue and provides data and a color-coded map of tissue oximetry values, enabling clinicians to quickly and efficiently determine superficial tissue oxygenation.

1997

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$1.8M

Latest Deal Amount

$13.6M

Total Amount Raised

Description

Developer of medical imaging devices designed to assess oxyhemoglobin, deoxyhemoglobin and oxyhemoglobin saturation in superficial tissue for a number of key healthcare applications. The company's medical imaging devices use a proprietary spectrometer to measure light absorption in blood molecules to determine levels of oxyhemoglobin and deoxyhemoglobin and oxygen saturation in superficial tissue and provides data and a color-coded map of tissue oximetry values, enabling clinicians to quickly and efficiently determine superficial tissue oxygenation.

Website:

www.hypermed.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Other Devices and Supplies

Primary Office

8700 Trail Lake Drive West Suite 200 Memphis, TN 38125United States +1 (844) 497-7633
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore HyperMed Imaging's full profile, request a free trial.

HyperMed Imaging Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

HyperMed Imaging Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

HyperMed Imaging Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Biomark CapitalVenture CapitalMinority000 0000000 0000
Burrill & CoMerchant Banking FirmMinority000 0000000 0000
DWS InvestmentsVenture CapitalMinority000 0000000 0000
GBP CapitalVenture CapitalMinority000 0000000 0000
Biomark Capital Venture Capital
Burrill & Co Merchant Banking Firm
DWS Investments Venture Capital
GBP Capital Venture Capital

HyperMed Imaging Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Mark DartyChief Executive Officer
Mark Darty Chief Executive Officer

HyperMed Imaging Board Members (2)

NameRepresentingRoleSinceContact
Info
David WetherellBiomark CapitalFounder & Managing Partner000 0000
Douglas Lind MDBiomark CapitalManaging Director000 0000
David Wetherell Founder & Managing Partner Biomark Capital
Douglas Lind MD Managing Director Biomark Capital
Request full access to PitchBook